Notably, one report focusing on the protective effect of insulin treatment on COVID-19 outcomes involved patients with T1DM and, revealed the opposite conclusion from our results (including mostly T2DM patients), indicating that a different approach to insulin therapy may be needed according to the type of diabetes. The gene discussed is INS; the disease is type 1 diabetes mellitus.